One-dose HPV vaccination could eliminate cervical cancer in Canada

Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modeling in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240787.

Mercy Terminates Contracts with Anthem Blue Cross Blue Shield

What You Should Know: – Mercy, a healthcare provider in Missouri, has announced its plans to terminate contracts with Anthem Blue Cross Blue Shield in

September 10, 2024

FDA seeks feedback on expansion of premarket cybersecurity guidance

Dive Brief: The Food and Drug Administration has requested feedback on plans to add a new section to the premarket cybersecurity guidance finalized last year. Through

March 13, 2024

ARPA-H funding boosts Wyss Institute’s RNA therapeutic project

With the award for up to $27 million from the Advanced Research Projects Agency for Health (ARPA-H), a collaborative research project at the Wyss Institute

July 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.